R&D In Brief
This article was originally published in The Tan Sheet
Executive Summary
Acetaminophen and ovarian cancer: A meta-analysis published in the July British Journal of Clinical Pharmacology "supports a protective association between acetaminophen use and ovarian cancer and provides evidence for a dose effect." However, the potential association between the drug and the disease "deserves further verification, since proof of chemoprevention would represent a major public health advance," Stefanos Bonovas, University of Athens, Greece, et al., state. Researchers analyzed eight studies (four case-control and four cohort studies) published between 1998 and 2004 and concluded that an inverse association exists between acetaminophen use and ovarian cancer risk. The association "was marginally significant assuming a random-effects model...but not statistically significant assuming a fixed-effects model"...